secwatch.observer — SEC 8-K summary
======================================

Issuer:     Senti Biosciences, Inc. (SNTI)
CIK:        0001854270
Form:       8-K
Filed at:   2026-03-19T23:59:59+00:00
Accession:  0001628280-26-019789
Event type: other_material
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Senti Biosciences cuts leased space 50% to 45,955 sq ft, amends sublease with GeneFab
--------------------------------------------------------------------------------

- Leased premises reduced from ~91,910 to ~45,955 rentable sq ft effective Sept 1, 2025.
- Monthly base rent for remaining space ranges $188,311 (2025-2026) to $293,010 (2032).
- Landlord may draw $2.0M from existing $2.76M letter of credit; balance drops to $760,000.
- Company paid or obtained payment of $1.0M reduction fee to landlord under consent amendment.
- Outstanding rent of $1,374,005 from GeneFab may be satisfied via prepayment credit or cash by Sept 1, 2026.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026019789/0001628280-26-019789-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1854270/000162828026019789/snti-20260317.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-019789

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer